PADAYATTIL JOSE, SEENA
 Distribuzione geografica
Continente #
NA - Nord America 3.346
AS - Asia 1.702
EU - Europa 703
SA - Sud America 320
AF - Africa 244
Continente sconosciuto - Info sul continente non disponibili 63
OC - Oceania 21
Totale 6.399
Nazione #
US - Stati Uniti d'America 3.203
SG - Singapore 514
CN - Cina 341
VN - Vietnam 334
BR - Brasile 212
HK - Hong Kong 140
IT - Italia 104
DE - Germania 86
FI - Finlandia 59
GB - Regno Unito 52
FR - Francia 47
SE - Svezia 47
NL - Olanda 46
BD - Bangladesh 40
CA - Canada 40
IN - India 38
JP - Giappone 32
RU - Federazione Russa 30
PL - Polonia 29
IQ - Iraq 26
AR - Argentina 25
TR - Turchia 21
CI - Costa d'Avorio 19
BE - Belgio 18
EC - Ecuador 18
AT - Austria 17
CO - Colombia 17
IE - Irlanda 15
PK - Pakistan 15
MA - Marocco 14
ID - Indonesia 13
MX - Messico 13
SA - Arabia Saudita 12
UA - Ucraina 12
PH - Filippine 11
BA - Bosnia-Erzegovina 10
CZ - Repubblica Ceca 10
EG - Egitto 10
JM - Giamaica 10
LB - Libano 10
NP - Nepal 10
PY - Paraguay 10
TH - Thailandia 10
DJ - Gibuti 9
MG - Madagascar 9
RO - Romania 9
TJ - Tagikistan 9
TN - Tunisia 9
TW - Taiwan 9
UZ - Uzbekistan 9
YT - Mayotte 9
ZA - Sudafrica 9
CM - Camerun 8
CY - Cipro 8
ES - Italia 8
MD - Moldavia 8
MW - Malawi 8
MY - Malesia 8
PE - Perù 8
VE - Venezuela 8
AF - Afghanistan, Repubblica islamica di 7
AO - Angola 7
BJ - Benin 7
BY - Bielorussia 7
CH - Svizzera 7
CL - Cile 7
CR - Costa Rica 7
GR - Grecia 7
HN - Honduras 7
HR - Croazia 7
IS - Islanda 7
KE - Kenya 7
KG - Kirghizistan 7
KH - Cambogia 7
KZ - Kazakistan 7
PR - Porto Rico 7
XK - ???statistics.table.value.countryCode.XK??? 7
AE - Emirati Arabi Uniti 6
AM - Armenia 6
AZ - Azerbaigian 6
DZ - Algeria 6
ET - Etiopia 6
LA - Repubblica Popolare Democratica del Laos 6
LT - Lituania 6
ML - Mali 6
MZ - Mozambico 6
NG - Nigeria 6
PA - Panama 6
PT - Portogallo 6
SN - Senegal 6
SO - Somalia 6
YE - Yemen 6
AL - Albania 5
AU - Australia 5
BF - Burkina Faso 5
BO - Bolivia 5
CV - Capo Verde 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
EU - Europa 5
Totale 6.134
Città #
Ashburn 400
Fairfield 399
San Jose 336
Singapore 318
Woodbridge 235
Chandler 228
Houston 178
Ann Arbor 173
Cambridge 155
Seattle 132
Wilmington 123
Hong Kong 120
Beijing 91
Ho Chi Minh City 89
Hanoi 72
Santa Clara 63
Boardman 42
Los Angeles 42
New York 40
Munich 33
San Diego 33
Council Bluffs 29
Medford 28
Princeton 28
Des Moines 27
Dong Ket 27
Helsinki 26
Bytom 24
Lauterbourg 24
Nanjing 22
Tokyo 20
Abidjan 19
Frankfurt am Main 19
Da Nang 17
Haiphong 16
Padova 16
Buffalo 15
Baghdad 14
Montreal 14
Orem 13
Chicago 12
Dublin 12
Redondo Beach 12
São Paulo 11
Toronto 10
Turku 10
Vienna 10
Dushanbe 9
Milan 9
Nanchang 9
Boston 8
Dallas 8
Guangzhou 8
Kingston 8
London 8
Stockholm 8
Tashkent 8
Zhengzhou 8
Antananarivo 7
Bangkok 7
Cairo 7
Hefei 7
Istanbul 7
Nuremberg 7
Phoenix 7
Poplar 7
Pristina 7
Redwood City 7
Amsterdam 6
Baku 6
Bamako 6
Bishkek 6
Biên Hòa 6
Brooklyn 6
Can Tho 6
Chennai 6
Cotonou 6
Dakar 6
Luanda 6
Mamoudzou 6
Nairobi 6
Panama City 6
Phnom Penh 6
Quito 6
San Juan 6
Shenyang 6
Vientiane 6
Yerevan 6
Addis Ababa 5
Athens 5
Atlanta 5
Belo Horizonte 5
Brussels 5
Caracas 5
Chisinau 5
Conakry 5
Dar es Salaam 5
Djibouti 5
Falkenstein 5
Falls Church 5
Totale 4.118
Nome #
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 336
Laboratory testing for antiphospholipid syndrome 290
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome 282
Antiphospholipid syndrome and the heart: A case series and literature review 275
Consequences of warfarin suspension after major bleeding in very elderly patients with non valvular atrial fibrillation 269
Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles 264
APS - Diagnostics and challenges for the future 256
Quantitative analysis of mitral valve geometry by transthoracic three-dimensional echocardiography: accuracy, feasibility, reproducibility and reference values 254
The Paradox of the Lupus Anticoagulant: History and Perspectives 254
Diagnosis and therapy of antiphospholipid syndrome 250
Laboratory Diagnostics of Antiphospholipid Syndrome 249
Lupus anticoagulant testing: Diluted Russell Viper Venom Time (dRVVT) 232
Antiphospholipid syndrome: antibodies to Domain 1 of β2-glycoprotein 1 correctly classify patients at risk 229
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant 225
Left ventricular myocardial strain by three-dimensional speckle-tracking echocardiography in healthy subjects: Reference values and analysis of their physiologic and technical determinants 225
Reference ranges for left ventricular geometry and function by 3D echocardiography using a vendor-independent software for quantitative analysis 223
Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial 220
Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naïve patients with non-valvular atrial fibrillation: Propensity score matched cohort study 219
A Bridging Protocol in High-Thrombotic Risk Mechanical Valve Bearers Undergoing Surgery or Invasive Procedures 215
Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case-control study 212
Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation 211
An unusual acute coronary syndrome: undisclosed disease hidden under a confounding clinical presentation 202
Correct laboratory approach to APS diagnosis and monitoring 196
Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA2DS2VASc 1 or 2): A treatment dilemma 189
. Left ventricular myocardial strain by three-dimensional speckle-tracking echocardiography in healthy volunteers: a normative study 180
Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort study 179
Normal left ventricular mechanics by two-dimensional speckle-tracking echocardiography. Reference values in healthy adults 163
Which are the optimal settings of 3D datasets used for left ventricular quantitative analysis by three-dimensional speckle-tracking echocardiography? 100
Totale 6.399
Categoria #
all - tutte 18.013
article - articoli 18.013
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.026


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022438 0 65 53 30 15 30 32 49 13 11 35 105
2022/2023382 71 49 8 59 51 43 3 33 39 2 22 2
2023/2024146 5 22 13 14 5 25 11 19 5 3 9 15
2024/2025788 0 48 47 34 96 11 69 75 56 19 135 198
2025/20262.907 148 239 336 393 277 130 495 208 363 153 109 56
2026/2027146 81 65 0 0 0 0 0 0 0 0 0 0
Totale 6.399